Enjoy a flat 15% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!

What fueled the previous growth in the trulicity market?

The market size for Trulicity has experienced robust growth in the recent past. Its growth is projected to increase from $7,320 million in 2024 to $7,980 million in 2025, corresponding to a compound annual growth rate (CAGR) of 9%. Factors contributing to this growth during the historic period include a rise in obesity rates, an expanding diabetic population, expansion in the pharmaceutical sector, the proliferation of unhealthy lifestyles, the untapped potential of therapies demonstrated, and an escalation in healthcare spending.

What will be the trulicity market size in the future?

Expectations are high for robust expansion within the trulicity market in the coming years. The market size is predicted to reach $11,180 million by 2029, with a compound annual growth rate (CAGR) of 8.8%. The anticipated growth within the forecast period is likely a consequence of the increasing adaptation of digital health technology, enhanced health consciousness amongst the public, the surge in awareness and educational programs, the rising demand for groundbreaking therapies, and expanded healthcare access initiatives. The forecast period’s primary trends entail technological incorporation, strategic alliances, product advancement, a shift towards personalized medications, combination treatments, and sustainable efforts.

Get your trulicity market report here!

https://www.thebusinessresearchcompany.com/report/trulicity-global-market-report

What main drivers are fueling expansion in the trulicity market?

The escalation in the number of people with diabetes is poised to boost the trulicity market. Diabetes, a chronic ailment characterized by high blood sugar levels, arises from the body’s inefficiency to produce or use insulin appropriately. If not efficiently managed, it can lead to serious complications. This surge in diabetes is attributed to factors such as urbanization, poor dietary habits, sedentary lifestyle, and genetic factors. The growing number of diabetes patients necessitates the need for effective treatment options like trulicity, hence heightening its demand. Trulicity aids in controlling blood sugar levels and enhances patient outcomes. For instance, data provided by the Office for Health Improvement and Disparities, a UK government department, in March 2024 showed that the proportion of type 1 diabetes patients in England receiving 8 care processes at GP practices participating in the NDA rose to 43.8% in March 2023 from 35.2% in 2022. Therefore, the rise in the diabetes population is fueling the expansion of the trulicity market.

What key areas define the segmentation of the global trulicity market?

The trulicitymarket covered in this report is segmented –

1) By Type: Prefilled Syringe Package; Vial Package

2) By Application: Type 2 Diabetes Management; Glycemic Control; Weight Management; Cardiovascular Risk Reduction

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19941&type=smp

Who are the dominant players expanding their reach in the trulicity market?

Major companies operating in the trulicity market include Eli Lilly And Company, Novo Nordisk

How are evolving market trends shaping trulicity Strategies?

Trend 1:

Text: The main direction in the Trulicity market is targeted towards the development of innovative Trulicity (dulaglutide) drug aimed at diminishing the risk of severe adverse cardiovascular occurrences. Trulicity (dulaglutide) is an injectable medication, administered once weekly, developed to improve blood sugar regulation in adults diagnosed with type 2 diabetes. It imitates the function of the GLP-1 hormone to boost insulin secretion, slow down the gastric emptying process and suppress appetite. For instance, in November 2022, the US Food and Drug Administration (FDA) gave approval to Eli Lilly and Company, a US pharmaceutical company, for the use of Trulicity (dulaglutide) as an additional aid to diet and exercise for enhancing glycemic control in both adult and pediatric patients aged 10 years and older living with type 2 diabetes mellitus (T2DM). The endorsement stems from a 26-week double-blind, placebo-controlled trial extended by another 26 weeks, which involved 154 pediatric patients, aged 10 and older, diagnosed with T2DM.

Strategic Investments in the Trulicity Market to Meet Growing Demand

A prominent trend within the Trulicity market is the application of strategic investment strategies, such as the construction of biologics production facilities, to achieve a competitive edge and fulfill the increasing demand. Biologics production facilities specifically refer to manufacturing plants designed for producing biologic drugs, which are complex treatments derived from living organisms, including monoclonal antibodies, vaccines, and cell and gene therapies. Case in point, Eli Lilly and Company, a US pharmaceutical company, disclosed their $450 million investment plan in January 2023 to expand their North Carolina manufacturing plant, aiming to increase the production of their diabetes drug Trulicity. This decision adds to a $1.7 billion investment in the same facility, with anticipation of starting production later this year, final completion by 2027, and creating 100 more jobs. In addition, Lilly is constructing two new facilities in Indiana and plans on investing €400 million in biologics production in Ireland. Looking forward, the company aims to allocate $2.5 billion to enhance manufacturing capacity in the upcoming years to cater to the surging demand and the launch of new products.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19941

Which regions are emerging as leaders in the trulicity market?

North America was the largest region in the trulicity market in 2024. The regions covered in the trulicity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Iron Deficiency Injectable Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

Generic Injectables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report

Lyophilized Injectable Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lyophilized-injectable-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: